Carlsmed Inc (CARL)

Currency in USD
14.57
+0.01(+0.07%)
Closed·
14.570.00(0.00%)
·
Unusual trading volume
CARL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.0415.19
52 wk Range
10.6517.19
Key Statistics
Prev. Close
14.56
Open
14.34
Day's Range
14.04-15.19
52 wk Range
10.65-17.19
Volume
248.32K
Average Volume (3m)
104.45K
1-Year Change
-
Book Value / Share
3.72
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CARL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
19.60
Upside
+34.52%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Carlsmed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Carlsmed Inc Company Profile

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Carlsmed Inc Earnings Call Summary for Q4/2025

  • Carlsmed reported 86% YoY revenue growth to $50.5M in 2025, with gross margin improving to 75.3% from 73.8% in 2024.
  • Operating expenses surged 55% to $68.6M, widening GAAP net loss to $29.6M from $24.3M; adjusted EBITDA negative $28.4M.
  • Company completed July 2025 IPO raising $100M+; stock fell 3.83% aftermarket to $13.06 despite strong revenue performance.
  • Management projects 2026 revenue of $70.17M with mid-70s gross margins, citing path to profitability through operational leverage.
  • Analysts set price targets of $17-$24, though rising expenses and widened losses present near-term profitability challenges.
Last Updated: 2026-02-25, 05:30 p/m
Read Full Transcript

Compare CARL to Peers and Sector

Metrics to compare
CARL
Peers
Sector
Relationship
P/E Ratio
−12.8x−5.3x−0.6x
PEG Ratio
−0.20−0.150.00
Price/Book
3.9x4.7x2.6x
Price / LTM Sales
7.7x3.3x3.3x
Upside (Analyst Target)
30.4%36.9%44.9%
Fair Value Upside
Unlock9.0%5.6%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 19.60
(+34.52% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Buy24.00+64.72%-MaintainDec 15, 2025
Truist Securities
Buy20.00+37.27%18.00MaintainNov 07, 2025
BTIG
Buy24.00+64.72%21.00MaintainNov 07, 2025
Goldman Sachs
Buy19.00+30.40%-MaintainAug 29, 2025

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
-0.32 / -0.35
Revenue / Forecast
15.20M / 14.90M
EPS Revisions
Last 90 days

CARL Income Statement

People Also Watch

10.26
EMBC
-2.10%
46.07
VPG
-2.52%
25.65
WAY
-1.42%

FAQ

What Is the Carlsmed (CARL) Stock Price Today?

The Carlsmed stock price today is 14.57 USD.

What Stock Exchange Does Carlsmed Trade On?

Carlsmed is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Carlsmed?

The stock symbol for Carlsmed is "CARL."

What Is the Carlsmed Market Cap?

As of today, Carlsmed market cap is 387.33M USD.

What Is Carlsmed's Earnings Per Share (TTM)?

The Carlsmed EPS (TTM) is -2.12.

When Is the Next Carlsmed Earnings Date?

Carlsmed will release its next earnings report on Apr 30, 2026.

From a Technical Analysis Perspective, Is CARL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Carlsmed Stock Split?

Carlsmed has split 0 times.

How Many Employees Does Carlsmed Have?

Carlsmed has 89 employees.

What is the current trading status of Carlsmed (CARL)?

As of Mar 01, 2026, Carlsmed (CARL) is trading at a price of 14.57 USD, with a previous close of 14.56 USD. The stock has fluctuated within a day range of 14.04 USD to 15.19 USD, while its 52-week range spans from 10.65 USD to 17.19 USD.

What Is Carlsmed (CARL) Price Target According to Analysts?

The average 12-month price target for Carlsmed is 19.60 USD, with a high estimate of 24 USD and a low estimate of 17 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +34.52% Upside potential.

What Is the CARL Premarket Price?

CARL's last pre-market stock price is 14.57 USD. The pre-market share volume is 330.00, and the stock has decreased by 0.01, or 0.07%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.